Astria Therapeutics's total assets for Q1 2025 were $310.39M, a decrease of -9.34% from the previous quarter. ATXS total liabilities were $21.10M for the fiscal quarter, a -8.67% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.